Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Mar 26;32(3):305-310.
doi: 10.1515/jpem-2018-0307.

Cinacalcet therapy in an infant with an R185Q calcium-sensing receptor mutation causing hyperparathyroidism: a case report and review of the literature

Thomas E Forman  1 , Anna-Kaisa Niemi  2 , Priya Prahalad  3 , Run Zhang Shi  4 , Laura M Nally  3   5
Affiliations
Review

Cinacalcet therapy in an infant with an R185Q calcium-sensing receptor mutation causing hyperparathyroidism: a case report and review of the literature

Thomas E Forman et al. J Pediatr Endocrinol Metab. .

Abstract

Background Neonatal severe hyperparathyroidism (NSHPT) is commonly treated with either parathyroidectomy or pharmacologic agents with varying efficacy and numerous side effects. Reports of using cinacalcet for NSHPT have increased, however, the effective dose for pediatric patients from the onset of symptoms through infancy has not been established. Case presentation We describe the clinical course of a newborn with a de novo R185Q mutation in the calcium-sensing receptor (CASR) gene, causing NSHPT. The infant received cinacalcet from the first days of life until 1 year of age. Conclusions Cinacalcet therapy effectively controlled the patient's serum calcium, phosphorus, and parathyroid hormone (PTH) levels without side effects.

Keywords: cinacalcet; familial hypocalciuric hypercalcemia; hypercalcemia; neonatal hyperparathyroidism; neonatal severe hyperparathyroidism.

PubMed Disclaimer

References

    1. Brown EM. Physiology and pathophysiology of the extracellular calcium-sensing receptor. Am J Med 1999;106:238–53.
    1. Brown EM. Editorial: mutant extracellular calcium-sensing receptors and severity of disease. J Clin Endocrinol Metab 2005;90:1246–8.
    1. Hofer AM, Brown EM. Extracellular calcium sensing and signalling. Nat Rev Mol Cell Biol 2003;4:530–8.
    1. Nesbit MA, Hannan FM, Howles SA, Babinsky VN, Head RA, et al. Mutations affecting G-protein subunit α 11 in hypercalcemia and hypocalcemia. N Engl J Med 2013;368:2476–86.
    1. Waldo GL, Ricks TK, Hicks SN, Cheever ML, Kawano T, et al. Kinetic scaffolding mediated by a phospholipase C-beta and Gq signaling complex. Science 2010;330:974–80.

Substances

LinkOut - more resources